Clinical Trial: Safety and Immunogenicity Study of a Multivalent Gonorrhoea Vaccine

U.S., Aug. 12 -- ClinicalTrials.gov registry received information related to the study (NCT07758972) titled 'Safety and Immunogenicity Study of a Multivalent Gonorrhoea Vaccine' on Aug. 05.

Brief Summary: The main goal of this trial is to evaluate the safety and immunogenicity of the candidate N. gonorrhoeae vaccine, LTB-NG6.

Study Start Date: Aug. 19

Study Type: INTERVENTIONAL

Condition: Neisseria Gonorrhea

Intervention: BIOLOGICAL: LTB-NG6

LTB-NG6 administrated at 5 different doses

OTHER: Sodium Chloride 0.9%

sodium chloride 0.9% used as a diluent in LTB-NG6 and as a placebo

Recruitment Status: RECRUITING

Sponsor: LimmaTech Biologics AG

Published by HT Digital Content Services with permission from Health Daily Digest....